← FDA Drug Approvals (Drugs@FDA)

FEBUXOSTAT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2019-12-30

Drug application

FDA Application #

ANDA210461

Application type

Abbreviated New Drug Application (Generic)

Brand name

FEBUXOSTAT

Generic name

FEBUXOSTAT

Active ingredients

FEBUXOSTAT

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MSN

Manufacturer

Novadoz Pharmaceuticals LLC

First approval

2019-12-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown